Navigation Links
Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
Date:5/11/2009

Real-time PCR test validated using clinical specimens confirmed

positive for Influenza A H1N1 Swine-origin flu virus

MADISON, N.J., May 11 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Focus Diagnostics infectious disease reference laboratory has introduced a laboratory-developed real-time polymerase chain reaction (PCR) test to aid in identifying Influenza A H1N1 Swine-origin (H1N1) flu virus ("S-OIV" or "novel H1N1"), also known as the Swine Flu. The Focus Diagnostics Influenza A H1N1 (Swine Flu) RNA Real-Time RT-PCR Test is the first laboratory testing service to be introduced by a commercial laboratory to aid in the identification of patients infected with the novel H1N1 virus and differentiate patients infected with other seasonal Influenza A strains. Focus Diagnostics has a track record of being first to market with new laboratory testing services for emerging infectious diseases, such as West Nile Virus, SARS, and chikungunya virus.

"Our new laboratory test will be an important tool to help health care professionals and public health authorities identify infected patients more quickly, promoting earlier diagnosis and treatment," said Jon R. Cohen, M.D., senior vice president and chief medical officer, Quest Diagnostics. "This capability could be particularly important if the novel H1N1 virus continues to spread in the U.S. or re-emerges this fall or winter. Public health officials in the U.S. have done an exceptional job of managing the current Influenza emergency, and we continue to work closely with them to assist their preparedness efforts."

Focus Diagnostics validated its new Influenza A H1N1 (Swine Flu) RNA Real-Time RT-PCR Test using clinical specimens submitt
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
2. Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State
3. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
4. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
5. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
6. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
7. Previous Claims of siRNA Therapeutic Effects Called into Question by Report in Human Gene Therapy
8. ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
9. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
10. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
11. Colorado Cancer Research Program Will Host Golf Event to Drive the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ... the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with ... and provides an update for shareholders detailing why a "YES" ... Dear Shareholders, As we reflect upon ...
(Date:1/23/2015)... Jan. 23, 2015  Mallinckrodt plc (NYSE: MNK ... approved a share repurchase program. The open-ended authorization permits ... Mallinckrodt plc ordinary shares. "Funding additional ... priorities as we continue to pursue a range of ...
(Date:1/23/2015)... , Jan. 23, 2015 Tianyin Pharmaceutical Inc. ... that specializes in the development and sale of patented ... and active pharmaceutical ingredients (API) today announced the business ... API operation. 1. Following the September 2014 ...
Breaking Medicine Technology:Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4
... 2011 Beckman Coulter, Inc. (NYSE: ... of products that simplify, automate and innovate complex ... that designs, manufactures, and markets innovative products and ... announced today that they have entered into a ...
... Feb. 7, 2011 Helix Medical, LLC, a ... soon begin construction on a new medical manufacturing facility in ... Coyol Free Trade Zone and Business Park in Alajuela, Costa ... more than $4M in the new plant that will soon ...
Cached Medicine Technology:Danaher to Acquire Beckman Coulter, Inc. 2Danaher to Acquire Beckman Coulter, Inc. 3Danaher to Acquire Beckman Coulter, Inc. 4Danaher to Acquire Beckman Coulter, Inc. 5
(Date:1/22/2015)... 23, 2015 The U.S. Pharmacopeial Convention ... Director of Clinical Pharmacy Services at North Carolina State’s ... of the 2015 Beal Award for Distinguished Volunteer Service—the ... relied on the contributions of volunteer experts to direct ...
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the ... created for kids with cancer. The Chemo Duck App, available on ... with enjoyable games to help children of all ages living with ... to keep kids entertained, educated and at ease while waiting for ...
(Date:1/22/2015)... January 22, 2015 Blue Cross and Blue ... who exemplify what it means to “Live Fearless.” ... people to share their stories about how they or someone ... inspired others by living in the moment. By telling these ...
(Date:1/22/2015)... York (PRWEB) January 22, 2015 Thousand ... Fresenius Medical Care recalled its GranuFlo and NaturaLyte dialysis ... litigation underway in U.S. District Court, District of Massachusetts, ... January 20th, the Court has remanded a case filed ...
(Date:1/22/2015)... 2015 A study recently published ... journal Medicine & Science in Sports & Exercise ... help reduce gastrointestinal (GI) problems associated with physical ... in the double-blind, placebo-controlled study took 10 grams ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... , National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas ... Quality Forum today launched a groundbreaking HIV/AIDS Atlas ( ... the HIV/AIDS epidemic in communities across the United States. ... a single location for the first time, painting a comprehensive ...
... Time for Fitness! , , LOS ANGELES, June 22 ... the park or along the beach. Now a brand new product ... equipment on wheels, but with a unique design to allow your ... new concept of fitness, will be introduced to California starting from ...
... oral care solution to suit the busy lifestyles of ... Crown Consumer Brands today announced the re-launch of DentaBurst(TM) ... remain intact, an improved, longer lasting freshmint flavor as ... re-launch. , , (Photo: ...
... June 22 MUSCLEPHARM(R) LLC, the rising star of ... much-anticipated product launch through each of Vitamin Shoppe,s 400+ ... about this nationwide launch of our entire line of ... now available to athletes in nearly every neighborhood across ...
... Transcend Medical, Inc., an ophthalmic device company dedicated to ... today that it has closed a $35 million Series ... its Transcend CyPass(TM) System, a novel proprietary system for ... investor HLM Venture Partners, along with other new investors ...
... Center of the University Children,s Hospital Zurich has ... non-invasive neurosurgery. Ten patients have been successfully treated ... fully non-invasive procedure opens new horizons for neurosurgery ... In the context of a clinical study ...
Cached Medicine News:Health News:MapHIV.org Shows 18% of Georgia's Counties are Seriously Impacted by HIV 2Health News:MapHIV.org Shows 18% of Georgia's Counties are Seriously Impacted by HIV 3Health News:Pumgo Fitness Scooter Will Highlight Venice Beach This Summer 2Health News:Crown Consumer Brands Re-Launches DentaBurst(TM) Freshening Teeth Cleaners 2Health News:MUSCLEPHARM Products Hit Vitamin Shoppe Shelves With a Bang! 2Health News:Transcend Medical Raises $35 Million Series B Round Towards Development of Novel Glaucoma Treatment 2Health News:Successful neurosurgery with transcranial MR-guided high-intensity focused ultrasound 2Health News:Successful neurosurgery with transcranial MR-guided high-intensity focused ultrasound 3
Specially designed wider jaws to help split soft nucleus, cross action, round handle, maximum opening 2.8 mm....
Irrigating nucleus chopper, tip angled 30 to side wedge shaped inferior edge with blunt tip and front notch for engaging iris end opening, 19 gauge. For use in the right hand....
Irrigating nucleus chopper, 0.6 mm dual sideports, 20 gauge. For the right handed surgeon....
Phaco chopper, a combination of a Sinskey hook and a pointed "quick chop" tip....
Medicine Products: